In contrast, post-onset treatment with anti-VEGF antibodies did not affect the development or severity of arthritis [43], indicating that angiogenesis regulated by VEGF plays a critical role in the early stage of arthritis progression. This evidence concerns the gene VEGFA and arthritic joint disease.